Chemical Component Summary

NameN-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide
IdentifiersN-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]quinoxaline-2-carboxamide
FormulaC25 H23 N7 O S
Molecular Weight469.561
TypeNON-POLYMER
Isomeric SMILESc1ccc(c(c1)c2cn3c(csc3n2)CN4CCNCC4)NC(=O)c5cnc6ccccc6n5
InChIInChI=1S/C25H23N7OS/c33-24(22-13-27-20-7-3-4-8-21(20)28-22)29-19-6-2-1-5-18(19)23-15-32-17(16-34-25(32)30-23)14-31-11-9-26-10-12-31/h1-8,13,15-16,26H,9-12,14H2,(H,29,33)
InChIKeyIASPBORHOMBZMY-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count57
Chiral Atom Count0
Bond Count62
Aromatic Bond Count26

Drug Info: DrugBank

DrugBank IDDB17057 
NameSRT-1720
Groups investigational
DescriptionSRT-1720 is an activator of NAD(+)-dependent histone deacetylase SIRT1.[A253147]
Synonyms
  • 2-quinoxalinecarboxamide, n-(2-(3-(1-piperazinylmethyl)imidazo(2,1-b)thiazol-6-yl)phenyl)-
  • SRT-1720
  • N-(2-(3-(1-piperazinylmethyl)imidazo(2,1-b)thiazol-6-yl)phenyl)-2-quinoxalinecarboxamide
CategoriesHeterocyclic Compounds, Fused-Ring
CAS number925434-55-5

Related Resource References

Resource NameReference
Pharos CHEMBL257991
PubChem 24180125
ChEMBL CHEMBL257991